Holen Sie sich die Stockscreener-App
17.70
15.19%
-3.17
Vorhandelsmarkt:
19.03
1.33
+7.51%
Schlusskurs vom Vortag:
$20.87
Offen:
$19.19
24-Stunden-Volumen:
49,054
Relative Volume:
0.65
Marktkapitalisierung:
$848.59M
Einnahmen:
$27,600
Nettoeinkommen (Verlust:
$-36.04M
KGV:
-22.21
EPS:
-0.7968
Netto-Cashflow:
$-1.66M
1W Leistung:
+17.37%
1M Leistung:
-13.70%
6M Leistung:
+429.78%
1J Leistung:
+302.27%
1-Tages-Spanne:
$17.42
$19.21
1-Wochen-Bereich:
$17.37
$20.97
52-Wochen-Spanne:
$2.76
$30.35
Nanobiotix Adr Stock (NBTX) Company Profile
Vergleichen Sie NBTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NBTX
Nanobiotix Adr
|
17.70 | 1.01B | 27,600 | -36.04M | -1.66M | -0.7968 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Nanobiotix Adr Stock (NBTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-28 | Eingeleitet | Guggenheim | Buy |
| 2023-12-08 | Eingeleitet | Leerink Partners | Outperform |
| 2021-01-06 | Eingeleitet | Evercore ISI | Outperform |
Nanobiotix Adr Aktie (NBTX) Neueste Nachrichten
Nanobiotix (NASDAQ:NBTX) Stock Price Up 10.3%Still a Buy? - MarketBeat
Short Interest in Nanobiotix S.A.Sponsored ADR (NASDAQ:NBTX) Declines By 60.7% - MarketBeat
Nanobiotix SA ADR Reports Revenue Surge Amid Strategic Advances - MSN
Nanobiotix enters royalty-based financing pact with HealthCare Royalty for $71M - TipRanks
Nanobiotix (NASDAQ:NBTX) Shares Gap UpStill a Buy? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Sees Strong Trading VolumeTime to Buy? - MarketBeat
Wayfair, Qorvo, Celestica, United Parcel Service, Regeneron Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday - NewsBreak: Local News & Alerts
Carter's, Newmont Corporation And Other Big Stocks Moving Lower In Monday's Pre-Market Session - inkl
Why Avidity Biosciences Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving Premarket - Benzinga
Nanobiotix (NASDAQ:NBTX) Shares Down 4.6%Time to Sell? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Shares Gap DownTime to Sell? - MarketBeat
Nanobiotix provides update on JNJ-1900 after Johnson & Johnson transfer - TipRanks
Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Nanobiotix S.A.Sponsored ADR (NASDAQ:NBTX) Sees Large Growth in Short Interest - MarketBeat
Karooooo Posts Downbeat Earnings, Joins ASP Isotopes And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
Orion, Nio, Alibaba Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Why Ericsson Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket - Benzinga
Pre Market Movers: NBTX, IMTX, QNRX See Big Swings - RTTNews
Why NioCorp Developments Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket - inkl
Nanobiotix (NASDAQ:NBTX) Trading Up 19.2%Here's Why - MarketBeat
Nanobiotix (NASDAQ:NBTX) Shares Down 12%Should You Sell? - MarketBeat
Weiss Ratings Reiterates "Sell (D-)" Rating for Nanobiotix (NASDAQ:NBTX) - MarketBeat
This Stock Is Up 440% in a Year. Is It an Undiscovered Star or a Flash in the Pan? - Barchart.com
Morning Market Movers: XBIO, UPC, GLTO Spark Big Moves - RTTNews
FY2027 EPS Estimates for Nanobiotix Boosted by HC Wainwright - Defense World
Why Concorde International Group Shares Are Trading Higher By 55%; Here Are 20 Stocks Moving Premarket - inkl
Morning Market Movers: SPRC, VALN, NBY, And Other Gainers & Losers - RTTNews
Nanobiotix (NASDAQ:NBTX) Reaches New 1-Year HighHere's Why - MarketBeat
NANOBIOTIX Announces Updated Phase 1 Results Continuing to Support JNJ-1900 (NBTXR3) Plus Anti-PD-1 as a Potential New 1L or 2L+ Option in Anti-PD-1 Naïve or Resistant R/M-HNSCC - GlobeNewswire Inc.
Nanobiotix (NASDAQ:NBTX) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
Stocks Moving Premarket: PEPG, WOK, ICU, And Other Gainers & Losers - RTTNews
Nanobiotix (NASDAQ:NBTX) Hits New 52-Week HighHere's Why - MarketBeat
Nanobiotix S.A. Sponsored ADR (NASDAQ:NBTX) Short Interest Up 23.7% in August - MarketBeat
Nanobiotix (NASDAQ:NBTX) Trading 11.8% HigherTime to Buy? - MarketBeat
Biotech Stocks Moving Premarket: QLGN, MBX, HSDT, And Other Gainers & Losers - RTTNews
Nanobiotix (NASDAQ:NBTX) Shares Up 5.7%What's Next? - MarketBeat
Nanobiotix announces new results from JNJ-1900 study - TipRanks
Nanobiotix Announces Voting Rights and Share Capital Update - The Globe and Mail
Nanobiotix (NASDAQ:NBTX) Stock Price Down 5.2% – Here’s Why - Defense World
Nanobiotix (NASDAQ:NBTX) Stock Price Up 2.9% – Should You Buy? - Defense World
Guggenheim Reaffirms Their Buy Rating on Nanobiotix (NBTX) - The Globe and Mail
Nanobiotix (NASDAQ:NBTX) Stock Price Down 2.5% – Should You Sell? - Defense World
Nanobiotix announces regulatory harmonization, new patent for JNJ-1900 - TipRanks
Finanzdaten der Nanobiotix Adr-Aktie (NBTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):